NDC 0006-0568

ZOLINZA

Vorinostat

ZOLINZA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Vorinostat.

• Product ID: 0006-0568_211f10f2-a84d-4e48-be1b-7709814d70ed
• NDC: 0006-0568
• Product Type: Human Prescription Drug
• Proprietary Name: ZOLINZA
• Generic Name: Vorinostat
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2006-10-06
• Marketing Category: NDA / NDA
• Application Number: NDA021991
• Labeler Name: Merck Sharp & Dohme Corp.
• Substance Name: VORINOSTAT
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0006-0568-40

120 CAPSULE in 1 BOTTLE (0006-0568-40)

• Marketing Start Date: 2006-10-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-0568-40 [00006056840]

ZOLINZA CAPSULE

• Marketing Category: NDA
• Application Number: NDA021991
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2006-10-06

Drug Details

Active Ingredients

Ingredient	Strength
VORINOSTAT	100 mg/1

OpenFDA Data

• SPL SET ID: cd86ee78-2781-468b-930c-3c4677bcc092
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • 58IFB293JI
• RxNorm Concept Unique ID - RxCUI:
  • 668606
  • 668579
• UPC Code:
  • 0300060568404

Pharmacological Class

• Histone Deacetylase Inhibitor [EPC]
• Histone Deacetylase Inhibitors [MoA]